HemaSphere (Mar 2022)
Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies
- Verena Petzer,
- Normann Steiner,
- Olga Angelova-Unterberger,
- Gabriele Hetzenauer,
- Kathrin Philipp-Abbrederis,
- Ella Willenbacher,
- Clemens Feistritzer,
- Wolfgang Willenbacher,
- Jakob Rudzki,
- Reinhard Stauder,
- Florian Kocher,
- Andreas Seeber,
- Andreas Pircher,
- Piotr Tymoszuk,
- Christian Irsara,
- Alexander Egger,
- Vilmos Fux,
- Markus Anliker,
- Eberhard Gunsilius,
- David Nachbaur,
- Stefan Schmidt,
- Dominik Wolf
Affiliations
- Verena Petzer
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- Normann Steiner
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- Olga Angelova-Unterberger
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- Gabriele Hetzenauer
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- Kathrin Philipp-Abbrederis
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- Ella Willenbacher
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- Clemens Feistritzer
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- Wolfgang Willenbacher
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- Jakob Rudzki
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- Reinhard Stauder
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- Florian Kocher
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- Andreas Seeber
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- Andreas Pircher
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- Piotr Tymoszuk
- 2 Data Analytics As a Service Tirol, DAAS Tirol, Innsbruck, Austria
- Christian Irsara
- 3 Central Institute of Clinical Chemistry and Laboratory Medicine Medical University of Innsbruck, Austria
- Alexander Egger
- 3 Central Institute of Clinical Chemistry and Laboratory Medicine Medical University of Innsbruck, Austria
- Vilmos Fux
- 3 Central Institute of Clinical Chemistry and Laboratory Medicine Medical University of Innsbruck, Austria
- Markus Anliker
- 3 Central Institute of Clinical Chemistry and Laboratory Medicine Medical University of Innsbruck, Austria
- Eberhard Gunsilius
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- David Nachbaur
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- Stefan Schmidt
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- Dominik Wolf
- 1 Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria
- DOI
- https://doi.org/10.1097/HS9.0000000000000686
- Journal volume & issue
-
Vol. 6,
no. 3
p. e686
Abstract
No abstracts available.